AbbVie Archives - DelveInsight

AbbVie

top-pharma-biotech-companies-by-revenue-share-drugs-therapies-2020-2021-worldwide
Top 7 Pharma Industry Leaders in 2020 By the Numbers

Pharmaceutical companies play a vital part in our lives and in helping us to live healthier lives. The pharmaceutical industry finds, develops, manufactures, and promotes medicines or pharmaceutic...


pharma-news
AbbVie & Genmab’s Collaboration; Lilly’s antisense neuro deal; COVID-19 treatment upda...

AbbVie Seals a USD 750 M Bispecific Antibody Cancer Drug Deal with Genmab  AbbVie is set to reimburse Genmab USD 750 million upfront for a stake in a pipeline of anti-cancer bispecif...


Non-Small Cell Lung Cancer Market Insights
Novel mutation-targeting therapies in the horizon to relieve the global healthcare burden NSCLC p...

Non-small cell lung cancer market is anticipated to increase in the 7MM from USD 9,730 million in 2017 by 2030.Worldwide, cancer claimed the lives of approximately 9.6 million people in 2018 ...


recent-pharma-news
AbbVie, Sofinnova back; Gilead, Kite ink; Biogen aims filing; Reversing diabetes

AbbVie, Sofinnova back USD 38 Million for Nitrome BiosciencesNitrome Biosciences contemplates treating Parkinson's disease and diabetes by targeting a new class of enzymes. The pharma raised U...


Coronavirus (COVID- 19)
The epidemic now has a name: COVID-19

Amid the breakout in Wuhan, China, the novel coronavirus has managed to invade the other countries across the globe. Till now, almost 25 countries including several Asian, northern American, Aust...


Pharma News
Thumbs down to NKTR-181, Lilly expands its insulin armamentarium

The US FDA has voted down Nektar Therapeutics’ opioid painkiller NKTR-181, designed to treat lower back pain. The FDA’s Anesthetic and Analgesic Drug Products Advisory Committee and the D...


Pharma news
AbbVie Sells bonds to Fund Allergan takeover

AbbVie has traded off its bonds worth USD 30 Billion to finance the purchase of the Allergan.  AbbVie this year in June has agreed to buy Allergan for USD 63 Billion, which is one of the ...


World Pharma News
Sanifit nets USD 80.9 M; FDA approves Dupixent for CRS; AbbVie buys Allergan

Sanifit raises USD 80.9 M to advance Calciphylaxis PipelineSanifit, a clinical-stage biopharmaceutical company, has raised USD 80.9 million ( €72.2 million ) in total private fundraising. The ...


Peloton Therapeutics
Neurogene raises $68.5M; AbbVie and Teneobio sign deal; 5AM Ventures nets

Neurogene raises USD 68.5 Million for rare neurological diseasesNeurogene netted USD 68.5 million to advance multiple gene therapy programs in its series A round. The idea is to take its major...


parkinson's
Voyager clears Neurocrine deal; Anthem speeds up launch; Lilly rushed its deal

Voyager clears Neurocrine agreement for Parkinson's gene therapyVoyager Therapeutics is signing a collaboration agreement with Neurocrine Biosciences that will remunerate the Cambridge, Massac...


Editor's Pick
Bone Metastasis Market: A Debilitating Consequence for Many Tumors

In advanced cancer patients, the most common site for the occurrence of metastasis is c...

Evaluating the Role of Digital Therapeutics as an Alternative to Conventional...

Depression is a mental condition characterized by prolonged series of poor moods, loss ...

Exploring the Market Potential of the Upcoming Therapies for the Myasthenia G...

Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It ...

Scrutinizing the West Syndrome Market Space from Growth Perspectives

West syndrome is a rare form of neurological disorder, an age-related specific Epilepti...

Recent Inclination of Pharma Companies, Emerging Pipeline Therapies Drive the...

Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.